![Fleur Wood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fleur Wood
Investor Relations Kontakt bei
BENEVOLENTAI S.A.
Profil
Fleur Wood is currently the Vice President-Investor Relations at BenevolentAI SA. Previously, she worked as the Head-Investor Relations at Vectura Group Ltd. from 2013 to 2017 and at Shield Therapeutics Plc in 2018.
She also held the position of Head-Investor Relations at hVIVO PLC.
Aktive Positionen von Fleur Wood
| Unternehmen | Position | Beginn |
|---|---|---|
| BENEVOLENTAI S.A. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Fleur Wood
| Unternehmen | Position | Ende |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Investor Relations Kontakt | 01.03.2018 |
| VECTURA GROUP | Investor Relations Kontakt | 01.12.2017 |
| HVIVO PLC | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Shield Therapeutics Plc
 Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
hVIVO PLC
 hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services | Commercial Services |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
